BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 8268223)

  • 1. Co-expression of mutant and normal human insulin receptors in COS 7 cells.
    Maegawa H; Kashiwagi A; Haruta T; Egawa K; Ugi S; Tachikawa-Ide R; Hasegawa M; Kobayashi M; Shigeta Y
    Biochim Biophys Acta; 1993 Dec; 1216(3):425-30. PubMed ID: 8268223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of unprocessed insulin proreceptors in COS 7 cells transfected with cDNA with Arg735----Ser735 point mutation at the cleavage site.
    Sugibayashi M; Shigeta Y; Teraoka H; Kobayashi M
    Metabolism; 1992 Aug; 41(8):820-6. PubMed ID: 1640858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of an insulin receptor mutant lacking the subunit processing site.
    Williams JF; McClain DA; Dull TJ; Ullrich A; Olefsky JM
    J Biol Chem; 1990 May; 265(15):8463-9. PubMed ID: 2187866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-translational processing and activation of insulin and EGF proreceptors.
    Lane MD; Ronnett G; Slieker LJ; Kohanski RA; Olson TL
    Biochimie; 1985; 67(10-11):1069-80. PubMed ID: 3000457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycosylation of Asn397 or Asn418 is required for normal insulin receptor biosynthesis and processing.
    Bastian W; Zhu J; Way B; Lockwood D; Livingston J
    Diabetes; 1993 Jul; 42(7):966-74. PubMed ID: 8513978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased hepatic insulin proreceptor-to-receptor ratio in diabetes: a possible processing defect.
    Dardevet D; Komori K; Grunfeld C; Rosenzweig SA; Buse MG
    Am J Physiol; 1991 Nov; 261(5 Pt 1):E562-71. PubMed ID: 1951680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of amino acid replacements within the tetrabasic cleavage site on the processing of the human insulin receptor precursor expressed in Chinese hamster ovary cells.
    Yoshimasa Y; Paul JI; Whittaker J; Steiner DF
    J Biol Chem; 1990 Oct; 265(28):17230-7. PubMed ID: 2211623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A leucine to proline mutation at position 233 in the insulin receptor inhibits cleavage of the proreceptor and transport to the cell surface.
    Maassen JA; Van der Vorm ER; Van der Zon GC; Klinkhamer MP; Krans HM; Möller W
    Biochemistry; 1991 Nov; 30(44):10778-83. PubMed ID: 1931997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional properties of a naturally occurring Trp1200----Ser1200 mutation of the insulin receptor.
    Moller DE; Yokota A; Ginsberg-Fellner F; Flier JS
    Mol Endocrinol; 1990 Aug; 4(8):1183-91. PubMed ID: 1963473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An assessment of human insulin receptor phosphorylation and exogenous kinase activity following deletion of 69 residues from the carboxyl-terminus of the receptor beta-subunit.
    Tavaré JM; Ramos P; Ellis L
    Biochem Biophys Res Commun; 1992 Oct; 188(1):86-93. PubMed ID: 1329749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfection of cDNA with G----T point mutation at the cleavage site of insulin receptors to COS 7 cells.
    Kobayashi M; Sugibayashi M; Sasaoka T; Egawa K; Shigeta Y; Tamaki M; Nakamura E; Teraoka H
    Biochem Biophys Res Commun; 1990 Mar; 167(3):1073-8. PubMed ID: 2322258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for exogenous substrate phosphorylation and dimer formation by the activated 190 kDa insulin proreceptor in vitro.
    Arakaki RF; Comi RJ; Gorden P
    Biochem Biophys Res Commun; 1989 Apr; 160(1):296-302. PubMed ID: 2653318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mutation in the insulin receptor that impairs proreceptor processing but not insulin binding.
    van der Vorm ER; Kuipers A; Kielkopf-Renner S; Krans HM; Möller W; Maassen JA
    J Biol Chem; 1994 May; 269(19):14297-302. PubMed ID: 8188715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leu 193 mutation in the cysteine rich region of the insulin receptor inhibits the cleavage of the insulin receptor precursor but not insulin binding.
    Takata Y; Imamura T; Haruta T; Egawa K; Takada Y; Sawa T; Yang GH; Kobayashi M
    Biochem Biophys Res Commun; 1994 Sep; 203(2):763-7. PubMed ID: 8093054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exon 11 enhances insulin binding affinity and tyrosine kinase activity of the human insulin proreceptor.
    Pashmforoush M; Yoshimasa Y; Steiner DF
    J Biol Chem; 1994 Dec; 269(51):32639-48. PubMed ID: 7798270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-translational changes in tertiary and quaternary structure of the insulin proreceptor. Correlation with acquisition of function.
    Olson TS; Bamberger MJ; Lane MD
    J Biol Chem; 1988 May; 263(15):7342-51. PubMed ID: 3366784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding specificity and intramolecular signal transmission of uncleaved insulin proreceptor in transformed lymphocytes from a patient with extreme insulin resistance.
    Sasaoka T; Shigeta Y; Takata Y; Sugibayashi M; Hisatomi A; Kobayashi M
    Diabetologia; 1989 Jun; 32(6):371-7. PubMed ID: 2668084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of the insulin proreceptor by hydrocortisone in cultured lymphocytes (IM-9 line).
    Rouiller DG; McElduff A; Hedo JA; Gorden P
    J Clin Invest; 1985 Aug; 76(2):645-9. PubMed ID: 4031068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baculovirus-directed expression of the human insulin receptor and an insulin-binding ectodomain.
    Paul JI; Tavaré J; Denton RM; Steiner DF
    J Biol Chem; 1990 Aug; 265(22):13074-83. PubMed ID: 2198283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific glycosylation site mutations of the insulin receptor alpha subunit impair intracellular transport.
    Collier E; Carpentier JL; Beitz L; Carol H; Taylor SI; Gorden P
    Biochemistry; 1993 Aug; 32(30):7818-23. PubMed ID: 8347587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.